These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2840520)

  • 1. Urinary pyrophosphate in patients with recurrent calcium urolithiasis and in healthy controls: a re-evaluation.
    Schwille PO; Rümenapf G; Wölfel G; Köhler R
    J Urol; 1988 Aug; 140(2):239-45. PubMed ID: 2840520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
    Wilson DR; Pylypchuk G; Ehrig U
    Can Med Assoc J; 1979 Mar; 120(6):666-9. PubMed ID: 436048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary phosphate excretion in the pathophysiology of idiopathic recurrent calcium urolithiasis: hormonal interactions and lipid metabolism.
    Schwille PO; Herrmann U; Schmiedl A; Kissler H; Wipplinger J; Manoharan M
    Urol Res; 1997; 25(6):417-26. PubMed ID: 9443652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrate in daily and fasting urine: results of controls, patients with recurrent idiopathic calcium urolithiasis, and primary hyperparathyroidism.
    Schwille PO; Scholz D; Paulus M; Engelhardt W; Sigel A
    Invest Urol; 1979 May; 16(6):457-62. PubMed ID: 447479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is magnesium a marker of disordered mineral metabolism in males with idiopathic recurrent calcium urolithiasis? Observations focussing on fasting magnesiuria and magnesiemia, protein and other substances in urine and plasma.
    Schmiedl A; Schwille PO
    Magnes Res; 2003 Sep; 16(3):192-205. PubMed ID: 14596324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascorbic acid in idiopathic recurrent calcium urolithiasis in humans--does it have an abettor role in oxalate, and calcium oxalate crystallization?
    Schwille PO; Schmiedl A; Herrmann U; Manoharan M; Fan J; Sharma V; Gottlieb D
    Urol Res; 2000 Jun; 28(3):167-77. PubMed ID: 10929425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible role of prostaglandin E2 in urinary stone formation.
    Hirayama H; Ikegami K; Shimomura T; Soejima H; Yamamoto T
    J Urol; 1988 Mar; 139(3):549-51. PubMed ID: 3422697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary pyrophosphate in normal subjects and in stone formers.
    O'Brien MM; Uhlemann I; McIntosh HW
    Can Med Assoc J; 1967 Jan; 96(2):100-3. PubMed ID: 4289320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of inorganic pyrophosphate by normal subjects and patients with renal calculi in north-western India and the effect of diclofenac sodium upon urinary excretion of pyrophosphate in stone formers.
    Sharma S; Vaidyanathan S; Thind SK; Nath R
    Urol Int; 1992; 48(4):404-8. PubMed ID: 1329300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and treatment of pediatric idiopathic urolithiasis-revisited.
    Alon US; Zimmerman H; Alon M
    Pediatr Nephrol; 2004 May; 19(5):516-20. PubMed ID: 15015063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrophosphate in synovial fluid and urine and its relationship to urinary risk factors for stone disease.
    Roberts NB; Dutton J; Helliwell T; Rothwell PJ; Kavanagh JP
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():529-34. PubMed ID: 1332571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimation of the concentration of urinary ionic calcium and its clinical role in urolithiasis].
    Minakata S
    Nihon Hinyokika Gakkai Zasshi; 1990 Dec; 81(12):1896-903. PubMed ID: 2292824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male hypercalciuric stone formers with low renal calcium reabsorption.
    Walker V; Cook P; Griffin DG
    J Clin Pathol; 2014 Apr; 67(4):355-60. PubMed ID: 24218027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Magnesium excretion in recurrent calcium urolithiasis].
    Pfab R; Hegemann M; Schütz W; Böttger I
    Urologe A; 1985 Sep; 24(5):296-8. PubMed ID: 4060380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO; Wipplinger J
    Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of inhibitor deficiency in urolithiasis. I. Rationale of urinary magnesium, citrate, pyrophosphate and glycosaminoglycan determinations.
    Akinci M; Esen T; Koçak T; Ozsoy C; Tellaloğlu S
    Eur Urol; 1991; 19(3):240-3. PubMed ID: 1649759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is idiopathic recurrent calcium urolithiasis in males a cellular disease? Laboratory findings in plasma, urine and erythrocytes, emphasizing the absence and presence of stones, oxidative and mineral metabolism: an observational study.
    Schwille PO; Manoharan M; Schmiedl A
    Clin Chem Lab Med; 2005; 43(6):590-600. PubMed ID: 16006254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.